Prospective study of 1 surgeon's experience with 115 cases using the Unfolder lens injection system

• Published in: Journal of cataract and refractive surgery Vol. 27; no. 9; p. 1437
• Main Authors: Ng, D T, Francis, I C, Schumacher, R S, Alexander, S L
• Format: Journal Article
• Language: English
• Published: United States 01-09-2001
• Subjects: Humans; Intraoperative Complications; Lens Implantation, Intraocular - instrumentation; Lenses, Intraocular; Phacoemulsification; Postoperative Complications; Prognosis; Prospective Studies; Visual Acuity
• ISSN: 0886-3350
• DOI: 10.1016/S0886-3350(01)00796-9

To describe the experience of 1 surgeon's first 115 cases using the Allergan Unfolder intraocular lens (IOL) injection system.
Free-standing day-surgery center, Chatswood, Australia.
After standard phacoemulsification, an SI-40NB IOL (Allergan) was implanted using the Unfolder. Data on complications and the success of implantation were collected prospectively.
Ninety-four percent of patients achieved a 1 month visual acuity of 6/6 or better. Of the 13 cases with a potential complication related to the Unfolder, all achieved a visual acuity of 6/6 or better. No complication affected the eye adversely or reduced visual acuity significantly.
Implantation of SI-40NB IOLs with the Unfolder led to no serious complications and gave satisfactory visual results.